Silence Therapeutics plc (SLN) Stock Profile — Insider Trades & Financials

Revenue$34.0K

Net Income-$11.8M

EPS$-0.63

Gross Margin64.7%

Market Cap$940.9M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Iain Ross

CEO & Executive Director

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

Founded: 1994
Employees: 120
Headquarters: LONDON, W6 7AP, United Kingdom
Website: www.silence-therapeutics.com

⚡

Core Efficiency

ROE?

-18.89%

ROA?

-8.95%

D/E Ratio?

1.11

Op. Margin?

-36650.00%

📊

Profitability Ratios

Net Margin?

-34617.65%

Loading company sections...

Silence Therapeutics plc

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

The morning brief, before the bell.

Silence Therapeutics plc

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades